Posts by Bruce Lynn

European Urology Publishes Results of SmartTarget Biopsy Trial

European Urology Publishes Results of SmartTarget Biopsy Trial

The recent issue of European Urology featured the article “The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing...

Bruce Lynn appointed CEO

Bruce Lynn appointed CEO

SmartTarget Ltd, a spinout of UCL (University College London) that has developed a CE-approved device for precision prostate biopsy and...

MRI Masterclass in Prostate Cancer for Urologists

SmartTarget is sponsoring the latest MRI Masterclass in prostate cancer for urologists at UCL Life Learning. This short course run by...